Company page

Collplant Biotechnologies Ltd.

Collplant Biotechnologies Ltd. is a public company traded under the ticker CLGN in the American market. The company focuses on developing innovative regenerative medicine solutions, particularly utilizing its proprietary collagen-based technologies. With a market capitalization of approximately $4.86 million, Collplant aims to advance treatments for various medical conditions through its research and product development efforts.